Characteristics of patients included in the study with pulmonary hypertension stratified by history of phosphodiesterase-5 inhibitor (PDE5i) and calcium channel blocker (CCB) use.
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Characteristics of patients included in the study with pulmonary hypertension stratified by history of phosphodiesterase-5 inhibitor (PDE5i) and calcium channel blocker (CCB) use.
创建时间：
2023-10-18
